Sudarshan Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 6.50 M
- Paid Up Capital ₹ 1.03 M
- Company Age 39 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 15.18 Cr
- Satisfied Charges ₹ 0.90 M
- Revenue Growth 29.78%
- Profit Growth 267.69%
- Ebitda 63.34%
- Net Worth 50.42%
- Total Assets 42.83%
About Sudarshan Pharmaceuticals
Sudarshan Pharmaceuticals Pvt Ltd (SPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 23 August 1985 and has a history of 39 years and six months. Its registered office is in Indore., Madhya Pradesh.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.50 M and a paid-up capital of Rs 1.03 M.
The company currently has active open charges totaling ₹15.18 Cr. The company has closed loans amounting to ₹0.90 M, as per Ministry of Corporate Affairs (MCA) records.
Kusum Randhar and Abhishek Randhar serve as directors at the Company.
Company Details
- Location Indore., Madhya Pradesh
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232MP1985PTC002978
- Company No.
002978
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Aug 1985
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
What products or services does Sudarshan Pharmaceuticals Pvt Ltd offer?
Sudarshan Pharmaceuticals Pvt Ltd offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Digestive System Drugs & Medicines, Dicyclomine Hydrochloride Medicine, Potassic Fertilizers, Potassium Chloride, Multivitamin Tablets & Capsules, Iron Folic Acid Tablet, Ferrous Compounds, Ferrous Sulphate.
Who are the key members and board of directors at Sudarshan Pharmaceuticals?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kusum Randhar ![]() | Director | 23-Aug-1985 | Current |
Abhishek Randhar ![]() | Director | 31-Mar-2024 | Current |
Financial Performance of Sudarshan Pharmaceuticals.
Sudarshan Pharmaceuticals Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 29.78% increase. The company also saw a substantial improvement in profitability, with a 267.69% increase in profit. The company's net worth Soared by an impressive increase of 50.42%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Sudarshan Pharmaceuticals?
In 2022, Sudarshan Pharmaceuticals had a promoter holding of 98.67% and a public holding of 1.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹151.80 M
₹0.90 M
Charges Breakdown by Lending Institutions
- State Bank Of India : 15.18 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
07 Feb 2024 | State Bank Of India | ₹3.20 M | Open |
17 Nov 2021 | State Bank Of India | ₹9.83 Cr | Open |
15 Dec 1997 | State Bank Of India | ₹5.03 Cr | Open |
04 Jul 2002 | State Bank Of India | ₹0.10 M | Satisfied |
15 Dec 1997 | State Bank Of India | ₹0.20 M | Satisfied |
How Many Employees Work at Sudarshan Pharmaceuticals?
Sudarshan Pharmaceuticals has a workforce of 1 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Sudarshan Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sudarshan Pharmaceuticals's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.